                         SEQUENCE LISTING

<110>  University of Florida Research Foundation, Inc.
 
<120>  Polypeptides and Vectors for Targeting HER2/neu Expressing Cells 
       and Uses Thereof

<130>  UF.992XC1PCT

<150>  US 61/487,476
<151>  2011-05-18

<160>  4     

<170>  PatentIn version 3.5

<210>  1
<211>  554
<212>  PRT
<213>  Human parvovirus B19

<400>  1

Met Thr Ser Val Asn Ser Ala Glu Ala Ser Thr Gly Ala Gly Gly Gly 
1               5                   10                  15      


Gly Ser Asn Ser Val Lys Ser Met Trp Ser Glu Gly Ala Thr Phe Ser 
            20                  25                  30          


Ala Asn Ser Val Thr Cys Thr Phe Ser Arg Gln Phe Leu Ile Pro Tyr 
        35                  40                  45              


Asp Pro Glu His His Tyr Lys Val Phe Ser Pro Ala Ala Ser Ser Cys 
    50                  55                  60                  


His Asn Ala Ser Gly Lys Glu Ala Lys Val Cys Thr Ile Ser Pro Ile 
65                  70                  75                  80  


Met Gly Tyr Ser Thr Pro Trp Arg Tyr Leu Asp Phe Asn Ala Leu Asn 
                85                  90                  95      


Leu Phe Phe Ser Pro Leu Glu Phe Gln His Leu Ile Glu Asn Tyr Gly 
            100                 105                 110         


Ser Ile Ala Pro Asp Ala Leu Thr Val Thr Ile Ser Glu Ile Ala Val 
        115                 120                 125             


Lys Asp Val Thr Asp Lys Thr Gly Gly Gly Val Gln Val Thr Asp Ser 
    130                 135                 140                 


Thr Thr Gly Arg Leu Cys Met Leu Val Asp His Glu Tyr Lys Tyr Pro 
145                 150                 155                 160 


Tyr Val Leu Gly Gln Gly Gln Asp Thr Leu Ala Pro Glu Leu Pro Ile 
                165                 170                 175     


Trp Val Tyr Phe Pro Pro Gln Tyr Ala Tyr Leu Thr Val Gly Asp Val 
            180                 185                 190         


Asn Thr Gln Gly Ile Ser Gly Asp Ser Lys Lys Leu Ala Ser Glu Glu 
        195                 200                 205             


Ser Ala Phe Tyr Val Leu Glu His Ser Ser Phe Gln Leu Leu Gly Thr 
    210                 215                 220                 


Gly Gly Thr Ala Thr Met Ser Tyr Lys Phe Pro Pro Val Pro Pro Glu 
225                 230                 235                 240 


Asn Leu Glu Gly Cys Ser Gln His Phe Tyr Glu Met Tyr Asn Pro Leu 
                245                 250                 255     


Tyr Gly Ser Arg Leu Gly Val Pro Asp Thr Leu Gly Gly Asp Pro Lys 
            260                 265                 270         


Phe Arg Ser Leu Thr His Glu Asp His Ala Ile Gln Pro Gln Asn Phe 
        275                 280                 285             


Met Pro Gly Pro Leu Val Asn Ser Val Ser Thr Lys Glu Gly Asp Ser 
    290                 295                 300                 


Ser Ser Thr Gly Ala Gly Lys Ala Leu Thr Gly Leu Ser Thr Gly Thr 
305                 310                 315                 320 


Ser Gln Asn Thr Arg Ile Ser Leu Arg Pro Gly Pro Val Ser Gln Pro 
                325                 330                 335     


Tyr His His Trp Asp Thr Asp Lys Tyr Val Thr Gly Ile Asn Ala Ile 
            340                 345                 350         


Ser His Gly Gln Thr Thr Tyr Gly Asn Ala Glu Asp Lys Glu Tyr Gln 
        355                 360                 365             


Gln Gly Val Gly Arg Phe Pro Asn Glu Lys Glu Gln Leu Lys Gln Leu 
    370                 375                 380                 


Gln Gly Leu Asn Met His Thr Tyr Phe Pro Asn Lys Gly Thr Gln Gln 
385                 390                 395                 400 


Tyr Thr Asp Gln Ile Glu Arg Pro Leu Met Val Gly Ser Val Trp Asn 
                405                 410                 415     


Arg Arg Ala Leu His Tyr Glu Ser Gln Leu Trp Ser Lys Ile Pro Asn 
            420                 425                 430         


Leu Asp Asp Ser Phe Lys Thr Gln Phe Ala Ala Leu Gly Gly Trp Gly 
        435                 440                 445             


Leu His Gln Pro Pro Pro Gln Ile Phe Leu Lys Ile Leu Pro Pro Ser 
    450                 455                 460                 


Gly Pro Ile Gly Gly Ile Lys Ser Met Gly Ile Thr Thr Leu Val Gln 
465                 470                 475                 480 


Tyr Ala Val Gly Ile Met Thr Val Thr Met Thr Phe Lys Leu Gly Pro 
                485                 490                 495     


Arg Lys Ala Thr Gly Arg Trp Asn Pro Gln Pro Gly Val Tyr Pro Pro 
            500                 505                 510         


His Ala Ala Gly His Leu Pro Tyr Val Leu Tyr Asp Pro Thr Ala Thr 
        515                 520                 525             


Asp Ala Lys Gln His His Arg His Gly Tyr Glu Lys Pro Glu Glu Leu 
    530                 535                 540                 


Trp Thr Ala Lys Ser Arg Val His Pro Leu 
545                 550                 


<210>  2
<211>  552
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Parvovirus B19 Chimeric VP2 Capsid Protein

<400>  2

Met Thr Ser Val Asn Ser Ala Glu Ala Ser Thr Gly Ala Gly Gly Gly 
1               5                   10                  15      


Gly Ser Asn Ser Val Lys Ser Met Trp Ser Glu Gly Ala Thr Phe Ser 
            20                  25                  30          


Ala Asn Ser Val Thr Cys Thr Phe Ser Arg Gln Phe Leu Ile Pro Tyr 
        35                  40                  45              


Asp Pro Glu His His Tyr Lys Val Phe Ser Pro Ala Ala Ser Ser Cys 
    50                  55                  60                  


His Asn Ala Ser Gly Lys Glu Ala Lys Val Cys Thr Ile Ser Pro Ile 
65                  70                  75                  80  


Met Gly Tyr Ser Thr Pro Trp Arg Tyr Leu Asp Phe Asn Ala Leu Asn 
                85                  90                  95      


Leu Phe Phe Ser Pro Leu Glu Phe Gln His Leu Ile Glu Asn Tyr Gly 
            100                 105                 110         


Ser Ile Ala Pro Asp Ala Leu Thr Val Thr Ile Ser Glu Ile Ala Val 
        115                 120                 125             


Lys Asp Val Thr Asp Lys Thr Gly Gly Gly Val Gln Val Thr Asp Ser 
    130                 135                 140                 


Thr Thr Gly Arg Leu Cys Met Leu Val Asp His Glu Tyr Lys Tyr Pro 
145                 150                 155                 160 


Tyr Val Leu Gly Gln Gly Gln Asp Thr Leu Ala Pro Glu Leu Pro Ile 
                165                 170                 175     


Trp Val Tyr Phe Pro Pro Gln Tyr Ala Tyr Leu Thr Val Gly Asp Val 
            180                 185                 190         


Asn Thr Gln Gly Ile Ser Gly Asp Ser Lys Lys Leu Ala Ser Glu Glu 
        195                 200                 205             


Ser Ala Phe Tyr Val Leu Glu His Ser Ser Phe Gln Leu Leu Gly Thr 
    210                 215                 220                 


Gly Gly Thr Ala Thr Met Ser Tyr Lys Phe Pro Pro Val Pro Pro Glu 
225                 230                 235                 240 


Asn Leu Glu Gly Cys Ser Gln His Phe Tyr Glu Met Tyr Asn Pro Leu 
                245                 250                 255     


Tyr Gly Ser Arg Leu Gly Val Pro Asp Thr Leu Gly Gly Asp Pro Lys 
            260                 265                 270         


Phe Arg Ser Leu Thr His Glu Asp His Ala Ile Gln Pro Gln Asn Phe 
        275                 280                 285             


Met Pro Gly Pro Leu Val Asn Ser Val Ser Thr Lys Glu Gly Asp Ser 
    290                 295                 300                 


Ser Ser Thr Gly Ala Gly Lys Ala Leu Thr Gly Leu Ser Thr Gly Thr 
305                 310                 315                 320 


Ser Gln Asn Thr Arg Ile Ser Leu Arg Pro Gly Pro Val Ser Gln Pro 
                325                 330                 335     


Tyr His His Trp Asp Thr Asp Lys Tyr Val Thr Gly Ile Asn Ala Ile 
            340                 345                 350         


Ser His Gly Gln Thr Thr Tyr Gly Asn Ala Glu Asp Lys Glu Tyr Gln 
        355                 360                 365             


Gln Gly Val Gly Arg Phe Pro Asn Glu Lys Glu Gln Leu Lys Gln Leu 
    370                 375                 380                 


Gln Gly Leu Asn Met His Thr Tyr Tyr Cys Asp Gly Phe Tyr Ala Cys 
385                 390                 395                 400 


Tyr Met Asp Val Arg Pro Leu Met Val Gly Ser Val Trp Asn Arg Arg 
                405                 410                 415     


Ala Leu His Tyr Glu Ser Gln Leu Trp Ser Lys Ile Pro Asn Leu Asp 
            420                 425                 430         


Asp Ser Phe Lys Thr Gln Phe Ala Ala Leu Gly Gly Trp Gly Leu His 
        435                 440                 445             


Gln Pro Pro Pro Gln Ile Phe Leu Lys Ile Leu Pro Pro Ser Gly Pro 
    450                 455                 460                 


Ile Gly Gly Ile Lys Ser Met Gly Ile Thr Thr Leu Val Gln Tyr Ala 
465                 470                 475                 480 


Val Gly Ile Met Thr Val Thr Met Thr Phe Lys Leu Gly Pro Arg Lys 
                485                 490                 495     


Ala Thr Gly Arg Trp Asn Pro Gln Pro Gly Val Tyr Pro Pro His Ala 
            500                 505                 510         


Ala Gly His Leu Pro Tyr Val Leu Tyr Asp Pro Thr Ala Thr Asp Ala 
        515                 520                 525             


Lys Gln His His Arg His Gly Tyr Glu Lys Pro Glu Glu Leu Trp Thr 
    530                 535                 540                 


Ala Lys Ser Arg Val His Pro Leu 
545                 550         


<210>  3
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  AHNP peptide

<400>  3

Tyr Cys Asp Gly Phe Tyr Ala Cys Tyr Met Asp Val 
1               5                   10          


<210>  4
<211>  12
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  anti-HER2/neu antibody rhu 4D5 CDR-H3 loop amino acids

<400>  4

Arg Trp Gly Gly Asp Gly Phe Tyr Ala Met Asp Val 
1               5                   10          


